rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Yasir B. Al-Wakeel

Director

Company insider

Files Form 4 as: Director, MaxCyte; Chief Financial Officer, Kronos Bio; Chief Financial Officer, Neon Therapeutics; CFO and Head of Corp Dev, Merrimack Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
37
Buys
1
Sells
2
Bought
$100K
Sold
$33K
Companies
4
Companies where not an officer
1
First trade
11 Aug 2015
Last trade
17 Jun 2026
Last filed
22 Jun 2026

Companies traded

Where they are an officer
Kronos BioOfficer · last 6 Jul 20231 buy · 2 sells
Neon TherapeuticsOfficer · last 6 May 20200 buys · 0 sells
Merrimack PharmaceuticalsOfficer · last 8 Feb 20160 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
MXCT MaxCyteDirector · Life-science tools · last 17 Jun 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Jun 2026filed 22 Jun 2026MXCT MaxCyteLife-science toolsSEC FORM 4 Code A—30,421 at $0.00filing
17 Jun 2026filed 22 Jun 2026MXCT MaxCyteoption or derivative · Life-science toolsSEC FORM 4 Code A—49,579 at $0.00filing
17 Jun 2026filed 22 Jun 2026MXCT MaxCyteoption or derivative · Life-science toolsSEC FORM 4 Code A—49,579 at $0.00filing
17 Jun 2026filed 22 Jun 2026MXCT MaxCyteLife-science toolsSEC FORM 4 Code A—30,421 at $0.00filing
18 Jun 2025filed 23 Jun 2025MXCT MaxCyteoption or derivative · Life-science toolsSEC FORM 4 Code A—50,790 at $0.00filing
18 Jun 2025filed 23 Jun 2025MXCT MaxCyteLife-science toolsSEC FORM 4 Code A—29,210 at $0.00filing
11 Jun 2024filed 13 Jun 2024MXCT MaxCyteoption or derivative · Life-science toolsSEC FORM 4 Code A—40,701 at $0.00filing
11 Jun 2024filed 13 Jun 2024MXCT MaxCyteLife-science toolsSEC FORM 4 Code A—21,367 at $0.00filing
6 Jul 2023filed 7 Jul 2023Kronos BioSEC FORM 4 Sold$17K9,617 at $1.75filing
22 Jun 2023filed 23 Jun 2023MXCT MaxCyteoption or derivative · Life-science toolsSEC FORM 4 Code A—50,000 at $0.00filing
20 Mar 2023filed 21 Mar 2023MXCT MaxCyteoption or derivative · Life-science toolsSEC FORM 4 Code A—40,000 at $0.00filing
24 Feb 2023filed 24 Feb 2023Kronos BioSEC FORM 4 Sold$16K9,026 at $1.74filing
15 Feb 2023filed 17 Feb 2023Kronos Biooption or derivativeSEC FORM 4 Code A—208,367 at $0.00filing
15 Feb 2023filed 17 Feb 2023Kronos BioSEC FORM 4 Code A—138,911 at $0.00filing
25 Jul 2022filed 27 Jul 2022Kronos Biooption or derivativeSEC FORM 4 Code A—40,000 at $0.00filing
25 Jul 2022filed 27 Jul 2022Kronos BioSEC FORM 4 Code A—53,600 at $0.00filing
29 Jun 2022filed 8 Jul 2022MXCT MaxCyteoption or derivative · Life-science toolsSEC FORM 4 Code A—26,900 at $0.00filing
15 Feb 2022filed 17 Feb 2022Kronos Biooption or derivativeSEC FORM 4 Code A—80,000 at $0.00filing
15 Feb 2022filed 17 Feb 2022Kronos BioSEC FORM 4 Code A—53,600 at $0.00filing
9 Aug 2021filed 11 Aug 2021MXCT MaxCyteoption or derivative · Life-science toolsSEC FORM 4 Code A—10,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.